Hadassah

Hadassah Mourns the Loss of Aretha Franklin and Urges Greater Awareness of Diagnosis and Treatment of Pancreatic Cancer

Friday, Aug 17 2018

Aretha Franklin (Courtesy CSU Archives/Everett Collection)

Sadly, the “queen of soul” Aretha Franklin passed away yesterday at age 76, due to an advanced pancreatic neuroendocrine tumor (pancreatic NET or PNET). 

Beloved by countless fans for the transcendent, timeless, and deeply moving quality of her music, Aretha left a legacy that musicians and music lovers will cherish.  Hadassah offers its condolences to Ms. Franklin’s family and relatives on the passing of this American music icon and legend.  The PNET that took Aretha’s life is a rare cancer (~ six percent of all pancreatic tumors), which develops from the abnormal growth of endocrine (hormone-producing) cells in the pancreas.

As Dr. Simona Glasberg, head of the Neuroendocrine Tumor Unit at the Hadassah Medical Organization, explains, "One of the major issues with these tumors is their timely diagnosis, as many times they are missed. Increasing awareness within the medical community and general population of these rare tumors is extremely important, as is the timely referral to a specialized center that is experienced in treating these rare cancers."

Whereas PNETs tend to grow slower than the usual aggressive pancreatic adenocarcinoma, Dr. Glasberg says, “they always have a malignant potential to spread locally or to other organs.  Often, they are diagnosed at an advanced stage of metastatic disease. The symptoms of PNETs are usually related to the tumor-mass growth and spread (e.g., abdominal pain, weight loss, loss of appetite, jaundice, etc.). However, in about 25 percent of cases, these tumors may produce specific hormonal-hypersecretion syndromes, causing diarrhea, severe weakness, sweating, and loss of consciousness. The Neuroendocrine Tumor Unit at Hadassah, with its dedicated multidisciplinary team, is a global leader in NET treatment and research.  Recently,  the European Neuroendocrine Tumor Society (ENETS) certified Hadassah’s unit as the only center of excellence in Israel and the Middle East.  

Related Stories

alt_text

Monday, Sep 16 2019

Hadassah Australia Will Help Ethiopian Israelis Achieve Their Dream

Barely 11 percent of Ethiopian Jewish students attend university in Israel, as compared to 42 percent of their counterparts in the general population.

READ MORE ›
alt_text

Friday, Sep 6 2019

Creating an Exceptional Bar Mitzvah Experience

Thirty members of the Moises Jafif family from Mexico, along with their friends, came to Israel to celebrate the Bar Mitzvah of Jak Jafif at the Kotel (the western wall of the ancient Temple Mount).

READ MORE ›
alt_text

Friday, Sep 6 2019

New, Larger Pediatric Bone Marrow Transplant Unit Opens at Hadassah

With a $4.75-million grant from The Leona M. and Harry B. Helmsley Charitable Trust, the Hadassah Medical Organization has opened a new pediatric bone marrow transplantation...

READ MORE ›
alt_text

Friday, Sep 6 2019

An Oasis of Peace

In the Jerusalem Post, Hadassah President Ellen Hershkin writes about Middle East peace, shared society and dignity for all.

READ MORE ›
SUPPORT HADASSAH HOSPITALS

Learn more about the Hadassah Medical Organization.

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More